1 |
A TPM3 mutation causing cap myopathy.
6
61
|
De Paula AM...Pouget J
|
19553118 |
2009 |
2 |
TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
6
|
Donkervoort S...Bonnemann CG
|
26418456 |
2015 |
3 |
Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin.
6
|
Lehtokari VL...Wallgren-Pettersson C
|
18382475 |
2008 |
4 |
Mutations in TPM3 are a common cause of congenital fiber type disproportion.
6
|
Clarke NF...North KN
|
18300303 |
2008 |
5 |
A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.
6
|
Penisson-Besnier I...Laing N
|
17376686 |
2007 |
6 |
An alphaTropomyosin mutation alters dimer preference in nemaline myopathy.
6
|
Corbett MA...Hardeman EC
|
15562513 |
2005 |
7 |
Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy.
6
|
Wattanasirichaigoon D...Beggs AH
|
12196661 |
2002 |
8 |
A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production.
6
|
Michele DE...Metzger JM
|
10587521 |
1999 |
9 |
Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy.
6
|
Tan P...Laing NG
|
10619715 |
1999 |
10 |
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.
6
|
Laing NG...Love DR
|
7704029 |
1995 |
11 |
[Congenital myopathy with selective hypotrophy of type I fibers].
6
|
Serratrice G...Pouget J
|
1221488 |
1975 |
12 |
Whole genome sequencing reveals biallelic PLA2G6 mutations in siblings with cerebellar atrophy and cap myopathy.
61
|
McMillan HJ...Kernohan KD
|
33576074 |
2021 |
13 |
Respiratory Failure as the Presenting Symptom in a Sporadic Case of Cap Myopathy.
61
|
Zheng Y...Yuan Y
|
33064836 |
2020 |
14 |
Markov State Modelling of Disease Courses and Mortality Risks of Patients with Community-Acquired Pneumonia.
61
|
Przybilla J...Scholz M
|
32121038 |
2020 |
15 |
Myopalladin promotes muscle growth through modulation of the serum response factor pathway.
61
|
Filomena MC...Bang ML
|
31647200 |
2020 |
16 |
Congenital myopathy with hanging big toe due to homozygous myopalladin (MYPN) mutation.
61
|
Merlini L...Nigro V
|
31133047 |
2019 |
17 |
Dominantly inherited distal nemaline/cap myopathy caused by a large deletion in the nebulin gene.
61
|
Kiiski KJ...Udd B
|
30679003 |
2019 |
18 |
The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
61
|
Borovikov YS...Redwood CS
|
30544720 |
2018 |
19 |
Relative Clinical and Cost Burden of Community-Acquired Pneumonia Hospitalizations in Older Adults in the United States-A Cross-Sectional Analysis.
61
|
Olasupo O...Brown JD
|
30200286 |
2018 |
20 |
The reason for the low Ca2+-sensitivity of thin filaments associated with the Glu41Lys mutation in the TPM2 gene is "freezing" of tropomyosin near the outer domain of actin and inhibition of actin monomer switching off during the ATPase cycle.
61
|
Avrova SV...Borovikov YS
|
29792862 |
2018 |
21 |
Molecular mechanisms of dysfunction of muscle fibres associated with Glu139 deletion in TPM2 gene.
61
|
Borovikov YS...Redwood CS
|
29196649 |
2017 |
22 |
A novel TPM2 gene splice-site mutation causes severe congenital myopathy with arthrogryposis and dysmorphic features.
61
|
Mroczek M...Kochanski A
|
27726070 |
2017 |
23 |
Recessive MYPN mutations cause cap myopathy with occasional nemaline rods.
61
|
Lornage X...Laporte J
|
28220527 |
2017 |
24 |
Complication of Community-Acquired Pneumonia (Including Cardiac Complications).
61
|
Restrepo MI...Anzueto A
|
27960213 |
2016 |
25 |
Improving outcomes in community-acquired pneumonia.
61
|
Bender MT...Niederman MS
|
26859379 |
2016 |
26 |
Severe congenital actin related myopathy with myofibrillar myopathy features.
61
|
Selcen D
|
25913210 |
2015 |
27 |
[The three-category classification of severe acute pancreatitis: a single-center pilot study].
61
|
Wu D...Qian J
|
25623558 |
2014 |
28 |
Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.
61
|
Rodriguez Cruz PM...Palace J
|
25127990 |
2014 |
29 |
ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.
61
|
Parray A...Saleem M
|
24752651 |
2014 |
30 |
Congenital myopathy with cap-like structures and nemaline rods: case report and literature review.
61
|
Piteau SJ...MacKenzie JJ
|
25079567 |
2014 |
31 |
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
61
|
Marttila M...Wallgren-Pettersson C
|
24692096 |
2014 |
32 |
Corticosteroids in the treatment of severe community-acquired pneumonia.
61
|
Ramsey TD...Gorman SK
|
24817026 |
2014 |
33 |
Novel TPM3 mutation in a family with cap myopathy and review of the literature.
61
|
Schreckenbach T...Claeys KG
|
24239060 |
2014 |
34 |
Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene.
61
|
Malfatti E...Romero NB
|
24095155 |
2013 |
35 |
The role of ultrasound in fetal congenital myopathy detection: a novel case of fetal-onset cap myopathy.
61
|
Tamblyn JA...Kilby MD
|
23804214 |
2013 |
36 |
Mechanism of recruitment and activation of the endosome-associated deubiquitinase AMSH.
61
|
Davies CW...Das C
|
24151880 |
2013 |
37 |
Community-acquired pneumonia.
61
|
Irfan M...Hasan R
|
23422417 |
2013 |
38 |
Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.
61
|
Davidson AE...Dowling JJ
|
23413262 |
2013 |
39 |
BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
61
|
Siddique HR...Saleem M
|
23671559 |
2013 |
40 |
Myopathies associated with β-tropomyosin mutations.
61
|
Tajsharghi H...Oldfors A
|
22749895 |
2012 |
41 |
Functional effects of congenital myopathy-related mutations in gamma-tropomyosin gene.
61
|
Robaszkiewicz K...Moraczewska J
|
22749829 |
2012 |
42 |
Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations.
61
|
Jarraya M...Carlier RY
|
22980765 |
2012 |
43 |
Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy.
61
|
Marttila M...Wallgren-Pettersson C
|
22084935 |
2012 |
44 |
Protein aggregation in congenital myopathies.
61
|
Goebel HH...Blaschek A
|
22172423 |
2011 |
45 |
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
61
|
Ellis RJ...Bodner D
|
20961696 |
2011 |
46 |
[Congenital myopathies - skeletal muscle diseases related to disorder of actin filament structure and functions].
61
|
Robaszkiewicz K...Moraczewska J
|
21677359 |
2011 |
47 |
Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3.
61
|
Waddell LB...Clarke NF
|
20554445 |
2010 |
48 |
Cap myopathy caused by a mutation of the skeletal alpha-actin gene ACTA1.
61
|
Hung RM...Vajsar J
|
20303757 |
2010 |
49 |
Angiogenesis as a strategic target for prostate cancer therapy.
61
|
Li Y...Cozzi PJ
|
19536866 |
2010 |
50 |
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.
61
|
Gust KM...Ringhoffer M
|
19724689 |
2009 |